Prenalterol

This classification denotes an adrenergic beta-1 receptor agonist, cardiotonic agent, and sympathomimetic with the molecular formula C12H19NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M4G34404CX, chemically known as phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, (s)- but generally known as prenalterol, which bears US NIH Compound Identifier 42396. European Medicines Agency schedules Prenalterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10027MIG. World Health Organization schedules prenalterol in its Anatomical Therapeutic Chemical (ATC) Classification. PRENALTEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule prenalterol under HS 29221980 and SITC 51461. As of Q4 2014, PRENALTEROL remains the US FDA Preferred Term for this commodity. SMILES: CC(C)NCC(COC1=CC=C(C=C1)O)O.